KRT18 and metabolic dysfunction-associated steatotic liver disease: Moreover, measuring the CK-18 concentration can be used as a biomarker to evaluate the effectiveness of treatment and enhance the management of nonalcoholic fatty liver disease in individuals with type-2 diabetes mellitus45.